Michael T. Sweeney
Director Técnico/Científico/I+D en RESVERLOGIX CORP. .
Fortuna: 6 523 $ al 30/04/2024
Cargos activos de Michael T. Sweeney
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| RESVERLOGIX CORP. | Director Técnico/Científico/I+D | 03/11/2014 | - |
Historial de carrera de Michael T. Sweeney
Antiguos cargos conocidos de Michael T. Sweeney.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Director Técnico/Científico/I+D | 06/05/2009 | 01/01/2014 |
| Corporate Officer/Principal | 01/12/2007 | 06/05/2009 | |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Director Técnico/Científico/I+D | 01/08/2003 | 01/09/2007 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/1995 | 01/01/2003 |
Zeneca Group Plc
 Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK. | Corporate Officer/Principal | - | - |
Formación de Michael T. Sweeney.
| The University of Liverpool | Doctorate Degree |
| The University of Manchester | Undergraduate Degree |
| University of London | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Reino Unido | 4 |
| Canadá | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| RESVERLOGIX CORP. | Health Technology |
| PFIZER, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Zeneca Group Plc
Zeneca Group Plc Pharmaceuticals: MajorHealth Technology Zeneca Group Plc used to develop & manufacture pharmaceutical products, agrochemicals and specialties chemicals. Its agrochemicals products include herbicides, insecticides and fungicides. The firm products were used by health care, agrochemical, paint, leather and imaging applications industries. The company was headquartered in London, UK. | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Michael T. Sweeney
- Experiencia
